Matinas BioPharma Holdings Inc (MTNB) Live Share Price, Invest From India

Matinas BioPharma Holdings Inc Stock Performance

as on May 14, 2026 at 4:07 am IST

Day's Low
$0.57
Day's Price Range
$0.59
$0.59
3.39%
Downside
52 Week's Low
52 Week's High
$0.48
52-Week Price Range
$3.09
$0.59
18.64%
Downside
423.73%
Upside

Matinas BioPharma Holdings Inc share price movements today

Previous Close: $0.59
Open: $0.57
Volume: 155.1K
Day's Low - High: $0.57 - $0.59
52 Week Low - High: $0.48 - $3.09

Matinas BioPharma Holdings Inc Historical Returns

1 Month Return: + 17.3 %
3 Month Return: -0.02 %
1 Year Return: -9.69 %
3 Year Return: -97.63 %
5 Year Return: -98.43 %

Matinas BioPharma Holdings Inc Stock Fundamentals & Key Indicators

Check Matinas BioPharma Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.1M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-6.9M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-166.59%

Matinas BioPharma Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Matinas BioPharma Holdings Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Matinas BioPharma Holdings Inc	BUY	$4.1M	-98.43%	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$38.0B	119.7%	71.39	12.55%
BeiGene, Ltd.	NA	$32.7B	NA	71.44	8.94%
Vertex Pharmaceuticals Inc	BUY	$110.4B	109.14%	25.84	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.7B	39.88%	17.39	29.65%

Stock Returns calculator for Matinas BioPharma Holdings Inc Stock including INR - Dollar returns

The Matinas BioPharma Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Matinas BioPharma Holdings Inc investment value today

Current value as on today

₹1,01,872

Returns

₹1,872

(+1.87%)

Returns from Matinas BioPharma Holdings Inc Stock

-₹9,231 (-9.23%)

Dollar Impact

₹11,103 (+11.1%)

Analyst Recommendation on Matinas BioPharma Holdings Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Matinas BioPharma Holdings Inc. Average target price of $30

Matinas BioPharma Holdings Inc Share Price Target

Get share price movements and forecasts by analysts on Matinas BioPharma Holdings Inc.

What analysts predicted

98.03%UPSIDE

Target Price

$30

Current Price

$0.59

Analyzed by

9 Analysts

Target

$30.00

Matinas BioPharma Holdings Inc target price $30, a slight upside of 98.03% compared to current price of $0.59. According to 9 analysts rating.

Indian Investors' Interest in Matinas BioPharma Holdings Inc Stock

Search interest for Matinas BioPharma Holdings Inc Stock has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 13, 2026 to May 13, 2026

Change:-42% versus previous 30 day period

Matinas BioPharma Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-1	-	-	-	-	0	-	-	-
Gross Profit	-3	0	-3	-2	-	0	0	-	0
Operating Income	-5	-5	-5	-4	-4	-1	-1	-1	-1
EBITDA	-5	-5	-5	-4	-	-1	-1	-2	-1
Interest Expense	0	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-5	-5	-4	-8	-1	-5	-2	-1
Income Tax Expense	0	0	-	-	-	0	-	-	-
Net Income	-5	-5	-5	-4	-8	-1	-5	-2	-1
Net Profit Margin	484.85%	0.00%	0.00%	0.00%	0.00%	-172.14%	0.00%	0.00%	0.00%

Matinas BioPharma Holdings Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	0	0	0	0	0	3	1	-	-
Gross Profit	0	-8	-6	-11	-14	-14	-13	1	0	-
Operating Income	-8	-16	-14	-18	-24	-24	-24	-23	-24	-6
EBITDA	-8	-16	-14	-18	-23	-24	-24	-22	-19	-6
Interest Expense	-	-	-	-	-	1	3	-	-	-
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-15	-14	-17	-22	-23	-20	-22	-24	-10
Income Tax Expense	0	0	0	-1	-1	-2	-7	0	0	-
Net Income	-7	-15	-14	-17	-22	-23	-20	-22	-24	-10
Net Profit Margin	0.00%	-10345.91%	-11760.39%	-19343.35%	-14176.98%	-70554.55%	-658.63%	-2093.25%	0.00%	0.00%

Matinas BioPharma Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-5	-5	-4	-8	-1	-5	-1	-1	-1
Operating Cash Flow	-5	-3	-3	-3	-2	-2	-1	-1	-1
Investing Cash Flow	2	-2	9	-	0	-	0	0	-
Financing Cash Flow	0	9	0	0	1	1	0	0	-
Change in Cash	-3	3	6	-3	0	0	-1	-1	-1

Matinas BioPharma Holdings Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-15	-14	-17	-22	-23	-20	-22	-24	-10
Operating Cash Flow	-11	-10	-14	-17	-15	-19	-15	-15	-7
Investing Cash Flow	0	0	-6	-40	16	4	13	9	0
Financing Cash Flow	15	15	29	48	6	0	0	9	3
Change in Cash	3	5	9	-9	8	-14	-2	2	-3

Insights on Matinas BioPharma Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, -1.09M → 962.0K (in $), with an average increase of 213.9% per quarter
NO EFFECT
Against Peers
In the last 1 year, BeOne Medicines Ltd has given 40.2% return, outperforming this stock by 49.9%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 32.2% return, outperforming this stock by 129.8%
NEGATIVE IMPACT
Price Dip
In the last 7 days, MTNB stock has moved down by -13.2%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -1.91M → -1.92M (in $), with an average decrease of 0.5% per quarter

About Matinas BioPharma Holdings Inc

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is MAT2203, an oral formulation of amphotericin B that is starting Phase 3 clinical trials for the treatment of aspergillosis and cryptococcosis, as well as prevention of invasive fungal infections in patients due to immunosuppressive therapy. It offers MAT2501, an orally administered formulation of amikacin. The company was incorporated in 2013 and is based in Bedminster, New Jersey.

Organisation	Matinas BioPharma Holdings Inc
Headquarters	1545 Route 206 South, Bedminster, NJ, United States, 07921
Industry	Biotechnology
CEO	Mr. Jerome D. Jabbour J.D.
E-voting on shares	Click here to vote

Key Management of Matinas BioPharma Holdings Inc

Name	Title
Mr. Jerome D. Jabbour J.D.	Co-Founder, Chairman, CEO, President & Interim CFO

FAQs

What is Matinas BioPharma Holdings Inc share price today?

Matinas BioPharma Holdings Inc share price today is $0.59 as on May 13, 2026 at 10:37 pm IST. Matinas BioPharma Holdings Inc share today touched a day high of $0.59 and a low of $0.57.

What is the 52 week high and 52 week low for Matinas BioPharma Holdings Inc share?

Matinas BioPharma Holdings Inc share touched a 52 week high of $3.09 on August 15, 2025 and a 52 week low of $0.48 on April 9, 2026. Matinas BioPharma Holdings Inc stock price today i.e. May 13, 2026 at 10:37 pm IST is trending at $0.59,which is 80.91% down from its 52 week high and 22.92% up from its 52 week low.

What is Matinas BioPharma Holdings Inc's market capitalisation today?

Matinas BioPharma Holdings Inc market capitalisation is $0.00T as on May 13, 2026 at 10:37 pm IST.

How to invest in Matinas BioPharma Holdings Inc Stock (MTNB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Matinas BioPharma Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Matinas BioPharma Holdings Inc Shares that will get you 2.5424 shares as per Matinas BioPharma Holdings Inc share price of $0.59 per share as on May 13, 2026 at 10:37 pm IST.

What is the minimum amount required to buy Matinas BioPharma Holdings Inc Stock (MTNB) from India?

Indian investors can start investing in Matinas BioPharma Holdings Inc (MTNB) shares with as little as ₹95.705 or $1 (as of May 13, 2026 at 10:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Matinas BioPharma Holdings Inc stock (as per the Rupee-Dollar exchange rate as on May 13, 2026 at 10:37 pm IST). Based on Matinas BioPharma Holdings Inc share’s latest price of $0.59 as on May 13, 2026 at 10:37 pm IST, you will get 16.9492 shares of Matinas BioPharma Holdings Inc. Learn more about fractional shares .

What are the returns that Matinas BioPharma Holdings Inc has given to Indian investors in the last 5 years?

Matinas BioPharma Holdings Inc stock has given -98.43% share price returns and 29.72% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?